IngentaConnect Search Results

Authors: Zografos, G. N.; Georgiadou, D.; Thomas, D.; Kaltsas, G.; Digalakis, M.

Source: Diseases of the Esophagus, Volume 22, Number 8, November 2009 , pp. 633-637(5)

Good clinical endpoints with denosumab in osteoporosis and cancer

Author: Doggrell, Sheila A

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 17, December 2009 , pp. 2939-2943(5)

Cost-Effectiveness of Using Clinical Risk Factors with and without DXA for Osteoporosis Screening in Postmenopausal Women

Authors: Mueller, Dirk; Gandjour, Afschin

Source: Value in Health, Volume 12, Number 8, November/December 2009 , pp. 1106-1117(12)

Publisher: Blackwell Publishing

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases

Authors: Boonen, S.; Kay, R.; Cooper, C.; Haentjens, P.; Vanderschueren, D.; Callewaert, F.; Milisen, K.; Ferrari, S.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1792-1804(13)

Publisher: Blackwell Publishing

Risedronic-acid: more cost effective with wider application

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Authors: Rabaglio, M.; Sun, Z.; Price, K. N.; Castiglione-Gertsch, M.; Hawle, H.; Thrlimann, B.; Mouridsen, H.; Campone, M.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Pienkowski, T.; Nogaret, J.-M.; Lng, I.; Smith, I.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1489-1498(10)

Publisher: Oxford University Press

Undertreatment of menopausal symptoms and novel options for comprehensive management

Author: Lewis, Vivian

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2689-2698(10)

Publisher: Informa Healthcare

Comment on Kanis et al.: “European guidance for the diagnosis and management of osteoporosis in postmenopausal women”

Author: Clausen, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1631-1631(1)

Publisher: Springer

Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression

Authors: Binkley, N.; Silverman, S.; Simonelli, C.; Santiago, N.; Kohles, J.; Dasic, G.; Sunyecz, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1595-1601(7)

Publisher: Springer

Greater osteoporosis educational outreach is desirable among Chinese immigrants in Chinatown, Chicago

Authors: Tan, S.; Ji, L.; Tsai, J.; Eng, J.; Ko, H.-J.; Yau, A.; Edwards, G.; Bunta, A.; Edwards, B.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1517-1522(6)

Publisher: Springer

Spinal deformity index (SDI) is a good predictor of incident vertebral fractures

Authors: Kerkeni, S.; Kolta, S.; Fechtenbaum, J.; Roux, C.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1547-1552(6)

Publisher: Springer

Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women

Authors: Bharadwaj, S.; Naidu, A.; Betageri, G.; Prasadarao, N.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1603-1611(9)

Publisher: Springer

Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis

Authors: Gennari, Luigi; Merlotti, Daniela; Nuti, Ranuccio

Source: Expert Review of Obstretrics and Gynecology, Volume 4, Number 6, November 2009 , pp. 607-617(11)

Publisher: Expert Reviews

Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?

Authors: Alexandersen, Peter; Karsdal, Morten A; Christiansen, Claus

Source: Women's Health, Volume 5, Number 6, November 2009 , pp. 637-647(11)

Publisher: Future Medicine

Bisphosphonates look best for osteoporosis in Thai women

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 5-5(1)

Publisher: Adis International

Zoledronic acid: reactions common but discontinuation rare

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 2-2(1)

Publisher: Adis International

Determinant Factors of Osteoporosis Patients' Reported Therapeutic Adherence to Calcium and/or Vitamin D Supplements: A Cross-Sectional, Observational Study of Postmenopausal Women

Authors: Sanfelix-Genovés, José; Gil-Guillén, Vicente F.; Orozco-Beltran, Domingo; Giner-Ruiz, Vicente; Pertusa-Martínez, Salvador; Reig-Moya, Begoña; Carratalá, Concepción

Source: Drugs & Aging, Volume 26, Number 10, 1 October 2009 , pp. 861-869(9)

Publisher: Adis International

Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective

Author: Boonen, Steven

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2335-2341(7)

Publisher: Informa Healthcare

Patient experience with a new teriparatide delivery device

Authors: Dore, Robin K.; Feldman, Robert G.; Taylor, Kathleen A.; See, Kyoungah; Dalsky, Gail P.; Warner, Margaret R.

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2413-2422(10)

Publisher: Informa Healthcare

Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women

Authors: Choi, Sung Hee; An, Jee Hyun; Lim, Soo; Koo, Bo Kyung; Park, Se Eun; Chang, Hyuck Jae; Choi, Sang Il; Park, Young Joo; Park, Kyong Soo; Jang, Hak Chul; Shin, Chan Soo

Source: Clinical Endocrinology, Volume 71, Number 5, November 2009 , pp. 644-651(8)

Publisher: Blackwell Publishing